Summary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
Tag:
Immunotherapy
-
-
Active Pharmaceutical Ingredients (API)Chugai Pharmaceuticals and Oncolys BioPhamaCompaniesTelomelysin
Oncolys BioPharma and Chugai Pharmaceuticals agree to Terminate Exclusive License Agreement on Oncolytic Viral Immunotherapy, OBP-301(Telomelysin)
by adminby adminKeypoints: Chugai, Oncolys BioPharma agree to terminate exclusive license agreement on oncolytic viral immunotherapy, OBP-301 The effective date of the termination will…
-
Active Agrochemical IngredientAtezolizumab
USFDA approves Roche’s Tecentriq (Atezolizumab) as Adjuvant Treatment for Non- small Cell Lung Cancer.
by adminby adminKeypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…